Follow
Zachary Goodman
Zachary Goodman
Inova Fairfax Medical Campus
Verified email at inova.org
Title
Cited by
Cited by
Year
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M Shiffman, ...
The Lancet 358 (9286), 958-965, 2001
82922001
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
JG McHutchison, SC Gordon, ER Schiff, ML Shiffman, WM Lee, VK Rustgi, ...
New England Journal of Medicine 339 (21), 1485-1492, 1998
45441998
Boceprevir for untreated chronic HCV genotype 1 infection
F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ...
New England Journal of Medicine 364 (13), 1195-1206, 2011
33552011
Liver biopsy
DC Rockey, SH Caldwell, ZD Goodman, RC Nelson, AD Smith
Hepatology 49 (3), 1017-1044, 2009
23732009
Boceprevir for previously treated chronic HCV genotype 1 infection
BR Bacon, SC Gordon, E Lawitz, P Marcellin, JM Vierling, S Zeuzem, ...
New England Journal of Medicine 364 (13), 1207-1217, 2011
22372011
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang, RG Gish, R De Man, A Gadano, J Sollano, YC Chao, AS Lok, ...
New England Journal of Medicine 354 (10), 1001-1010, 2006
20552006
Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
P Marcellin, TT Chang, SG Lim, MJ Tong, W Sievert, ML Shiffman, ...
New England Journal of Medicine 348 (9), 808-816, 2003
20492003
Lamivudine as initial treatment for chronic hepatitis B in the United States
JL Dienstag, ER Schiff, TL Wright, RP Perrillo, HWL Hann, Z Goodman, ...
New England Journal of Medicine 341 (17), 1256-1263, 1999
19511999
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai, D Shouval, AS Lok, TT Chang, H Cheinquer, Z Goodman, ...
New England Journal of Medicine 354 (10), 1011-1020, 2006
16762006
Recombinant interferon alfa therapy for chronic hepatitis C
AM Di Bisceglie, P Martin, C Kassianides, M Lisker-Melman, L Murray, ...
New England Journal of Medicine 321 (22), 1506-1510, 1989
15441989
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ...
Gastroenterology 122 (5), 1303-1313, 2002
14632002
Adefovir dipivoxil for the treatment of hepatitis B e antigen–negative chronic hepatitis B
SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ...
New England Journal of Medicine 348 (9), 800-807, 2003
14302003
Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
TT Chang, YF Liaw, SS Wu, E Schiff, KH Han, CL Lai, R Safadi, SS Lee, ...
Hepatology 52 (3), 886-893, 2010
12422010
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle–Lapostolle, S Bowden, S Locarnini, K Wursthorn, J Petersen, ...
Gastroenterology 126 (7), 1750-1758, 2004
11892004
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ...
Gastroenterology 131 (6), 1743-1751, 2006
11692006
Telbivudine versus lamivudine in patients with chronic hepatitis B
CL Lai, E Gane, YF Liaw, CW Hsu, S Thongsawat, Y Wang, Y Chen, ...
New England Journal of Medicine 357 (25), 2576-2588, 2007
11552007
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10292019
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht
Journal of hepatology 34 (5), 730-739, 2001
9952001
Grading and staging systems for inflammation and fibrosis in chronic liver diseases
ZD Goodman
Journal of hepatology 47 (4), 598-607, 2007
9872007
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
KL Lindsay, C Trepo, T Heintges, ML Shiffman, SC Gordon, JC Hoefs, ...
Hepatology 34 (2), 395-403, 2001
9592001
The system can't perform the operation now. Try again later.
Articles 1–20